TABLE 1.
Baseline Characteristics
| During the Pandemic (n=21) | 2019 (n=42) | |
|---|---|---|
| Age (y) | 64 (54-72) | 65 (56-74) |
| Male | 15 (71.4) | 31 (73.8) |
| Height (cm) | 169 (161-175) | 170 (162-172) |
| Weight (kg) | 75 (65-88) | 70 (65-80) |
| BMI | 26.80 (23.3-29.3) | 25.2 (23.1-27.0) |
| Comorbidities | ||
| Hypertension | 17 (81.0) | 33 (78.6) |
| Atrial fibrillation | 9 (42.9) | 10 (23.8) |
| Coronary artery disease | 8 (38.1) | 8 (19.0) |
| Respiratory disease | 3 (14.3) | 3 (7.1) |
| Dyslipidemia* | 13 (61.9) | 13 (31.0) |
| Diabetes mellitus | 6 (28.6) | 9 (21.4) |
| History of smoking | 11 (52.4) | 24 (57.1) |
| History of alcohol consumption | 10 (47.6) | 21 (50.0) |
| Medicine history | ||
| Anticoagulant | 5 (23.8) | 8 (19.0) |
| Antiplatelet | 3 (14.3) | 9 (21.4) |
| Bridging IVT | 7 (33.3) | 15 (35.7) |
| Wake-up stroke* | 7 (33.3) | 3 (7.1) |
| Local patients (from Beijing area) | 14 (66.7) | 21 (50.0) |
| Pretreatment NIHSS | 12 (11-15) | 15 (12-18) |
Data presented as median (interquartile range) or number (%).
BMI indicates body mass index; IVT, intravenous thrombolysis; MRS, modified Ranking Scale; NIHSS, National Institutes of Health Stroke Scale.
*
Between-group P<0.05.